An evaluation of case reports of patients with neuroleptic malignant syndrome found that dantrolene monotherapy appears to be associated with?
A higher incidence of mortality.
Reulbach U, Dütsch C, Biermann T, Sperling W, Thuerauf N, Kornhuber J, Bleich S. Managing an effective treatment for neuroleptic malignant syndrome. Crit Care. 2007;11(1):R4. doi: 10.1186/cc5148. PMID: 17222339; PMCID: PMC2151884.
Contributed by: Florida/USVI Poison Information Center-Jacksonville Toxicology Fellowship
Posted in Question Of The Day